Quantitative real-time polymerase chain reaction (qRT-PCR) restriction fragment length polymorphism (RFLP) method for monitoring highly conserved transgene expression during gene therapy

被引:4
作者
Bruzzone, Carol M.
Belcher, John D.
Schuld, Nathan J.
Newman, Kristal A.
Vineyard, Julie
Nguyen, Julia
Chen, Chunsheng
Beckman, Joan D.
Steer, Clifford J.
Vercellotti, Gregory M. [1 ]
机构
[1] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/j.trsl.2008.10.005
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Evaluation of the transfer efficiency of a rat heme oxygenase-1 (HO-1) transgene into mice requires differentiation of rat and mouse HO-1. However, rat and mouse HO-1 have 94% homology; antibodies and enzyme activity cannot adequately distinguish HO-1. We designed a quantitative real-time polymerase chain reaction (qRT-PCR) method to monitor HO-1 transcription relative to a housekeeping gene, GAPDH. The ratio of rat and mouse HO-1 mRNA could be estimated through restriction fragment length polymorphism (RFLP) analysis of the PCR products. In vitro, murine AML12 hepatocytes were transfected with rat HO-1. After 40 h, the total HO-1 mRNA was enriched 2-fold relative to control cells, and rat HO-1 comprised 84% of HO-1 cIDNA. In vivo, the rat HO-1 transgene was cloned into a Sleeping Beauty transposase (SB-Tn) construct and was injected hydrodynamically into a mouse model of sickle cell disease (SCD). After 21 days, there was a 32% enrichment of HO- I mRNA relative to control mice and the rat transgene comprised 88% of HO-1 cIDNA. After 21 days, HO-1 protein expression in liver was increased 2.5-fold. In summary, qRT-PCR RFLP is a useful and reliable method to differentiate the transgene from host gene transcription, especially when the host and transgene protein are identical or highly homologous. This method has translational applications to the design, delivery, and monitoring of gene-therapy vectors. (Translational Research 2008; 152:290-297)
引用
收藏
页码:290 / 297
页数:8
相关论文
共 24 条
[1]  
Aslan M, 2004, CELL MOL BIOL, V50, P95
[2]   Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice [J].
Belcher, JD ;
Mahaseth, H ;
Welch, TE ;
Otterbein, LE ;
Hebbel, RP ;
Vercellotti, GM .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (03) :808-816
[3]   Preferential delivery of the Sleeping Beauty transposon system to livers of mice by hydrodynamic injection [J].
Bell, Jason B. ;
Podetz-Pedersen, Kelly M. ;
Aronovich, Elena L. ;
Belur, Lalitha R. ;
McIvor, R. Scott ;
Hackett, Perry B. .
NATURE PROTOCOLS, 2007, 2 (12) :3153-3165
[4]   Gene transfer by adenovectors [J].
Brenner, M .
BLOOD, 1999, 94 (12) :3965-3967
[5]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[6]   Structure-function analysis of the inverted terminal repeats of the Sleeping Beauty transposon [J].
Cui, ZB ;
Geurts, AM ;
Liu, GY ;
Kaufman, CD ;
Hackett, PB .
JOURNAL OF MOLECULAR BIOLOGY, 2002, 318 (05) :1221-1235
[7]   A 2ND-GENERATION TRANSGENIC MOUSE MODEL EXPRESSING BOTH HEMOGLOBIN-S (HBS) AND HBS-ANTILLES RESULTS IN INCREASED PHENOTYPIC SEVERITY [J].
FABRY, ME ;
SENGUPTA, A ;
SUZUKA, SM ;
COSTANTINI, F ;
RUBIN, EM ;
HOFRICHTER, J ;
CHRISTOPH, G ;
MANCI, E ;
CULBERSON, D ;
FACTOR, SM ;
NAGEL, RL .
BLOOD, 1995, 86 (06) :2419-2428
[8]  
Haack A, 1999, HAEMOPHILIA, V5, P334
[9]   Gene transfer into nonhuman primate hematopoietic stem cells: Implications for gene therapy [J].
Hanazono, Y ;
Terao, K ;
Ozawa, K .
STEM CELLS, 2001, 19 (01) :12-23
[10]   The endothelial biology of sickle cell disease: Inflammation and a chronic vasculopathy [J].
Hebbel, RP ;
Osarogiagbon, R ;
Kaul, D .
MICROCIRCULATION, 2004, 11 (02) :129-151